B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
Determining the minimal clinically important difference criteria for the multidimensional fatigue inventory in a radiotherapy population
TL;DR: Improve the clinical utility of the Multidimensional Fatigue Inventory by establishing MCID criteria for the MFI sub-scales in a radiotherapy population and allow effect size calculations for determining sample size in future studies.
Journal ArticleDOI
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus
Bernard Mark Smithers,G. C. Couper,Janine Thomas,David Wong,David C. Gotley,Ian Martin,Jennifer Harvey,Damien Thomson,Euan Walpole,N. Watts,Bryan Burmeister +10 more
TL;DR: There was no correlation between the FDG-PET response and the histopathological response in patients with esophageal adenocarcinoma receiving neoadjuvant chemotherapy and/or chemoradiation therapy.
Journal ArticleDOI
Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial.
Gerald B Fogarty,Rachael L. Morton,Janette L. Vardy,Anna K. Nowak,Catherine Mandel,Peta M. Forder,Peta M. Forder,Angela Hong,George Hruby,Bryan Burmeister,Brindha Shivalingam,Haryana M. Dhillon,John F. Thompson +12 more
TL;DR: This trial is an international, prospective multi-centre, open-label, phase III randomised controlled trial comparing WBRT to observation following local treatment of intracranial melanoma metastases with surgery and/or SRS to provide the evidence that is currently lacking in treatment decision-making for patients with melanoma brain metastases.
Journal ArticleDOI
Factors influencing outcome following radio-chemotherapy for oesophageal cancer
James W. Denham,Bryan Burmeister,David Lamb,N. Spry,David J. Joseph,Christopher S. Hamilton,Eric Yeoh,Peter C. O'Brien,Quenten Walker +8 more
TL;DR: Conurrent radio-chemotherapy protocols can improve outcome in patients fit enough to tolerate these approaches, however, new strategies remain necessary, however.
A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus
Bryan Burmeister,Bernard Mark Smithers,L. Fitzgerald,Val Gebski,Peter G. Devitt,Stephen P. Ackland,David Joseph,Jeremy Millar,John B. North,Euan Walpole,James W. Denham +10 more
TL;DR: The findings are compatible with those from previous trials, indicating that the benefits of CT/RT are limited when surgical results are optimal, according to previous trials.